Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer

NCT06742021 is registered in ClinicalTrials.gov with Yunnan Cancer Hospital as lead sponsor.

NCT NCT06742021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06742021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer
Lead sponsor
Yunnan Cancer Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
November 11, 2024
Completion date
July 31, 2026
Enrollment
195 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer